Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Briacell dropping 30% after FASTTRACK

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Apr 14, 2022 11:46am

259 Views

Post# 34603983

Briacell dropping 30% after FASTTRACK

2days after receiving FDA Fasttrack designation, Briacell is dropping -30%!

Still has 164MM$ in market valuation, 2.2x our valuation, despite no patients rested yet and not even being a stand-alone treatment!

Breakthrough designation has more of a permanent effect on the market valuation because it is closer to market.

_____________

Pandora - (4/13/2022 9:12:31 AM)

RE:RE:RE:Perhaps Theralase can update

Some are getting it:

BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy

<< Previous

Bullboard Posts

Next >>

Mullen Group: Navigates market challenges towards success